Is Hidradenitis Suppurativa (HS) Autoimmune or Autoinflammatory?

Abstract

Hidradenitis Suppurativa (HS) is a chronic inflammatory skin disease characterized by painful recurrent nodules, abscesses, and sinus tracts, primarily affecting intertriginous areas such as the axillae and groin. Its pathogenesis remains incompletely understood, leading to ongoing debate about whether HS is best classified as an autoimmune or autoinflammatory disorder. This article reviews the current scientific perspectives on HS, exploring its immunological mechanisms and classification, as well as its implications for treatment. Additionally, the Ayurvedic perspective is introduced, providing a holistic framework for understanding and managing HS by addressing the root causes and restoring balance to the body.

Hidradenitis Suppurativa Autoimmune or Autoinflammatory

Introduction

Hidradenitis Suppurativa (HS), also known as acne inversa, is a chronic and debilitating condition that profoundly affects patients’ quality of life due to the pain, scarring, and psychosocial burden it imposes (Alikhan et al., 2009). Despite advances in understanding the disease, its exact pathogenesis and underlying causes remain poorly understood. One of the ongoing debates revolves around whether HS is primarily an autoimmune disease, driven by dysregulation of the adaptive immune system, or an autoinflammatory condition, involving dysfunction of the innate immune system. This uncertainty complicates its classification and treatment, further highlighting the need for a more holistic view of HS, such as that provided by Ayurveda.

Autoimmune vs. Autoinflammatory Diseases

Autoimmune DiseasesAutoimmune diseases are characterized by a breakdown in the adaptive immune system, resulting in the immune system attacking the body’s own tissues. In autoimmune diseases, autoreactive T cells and autoantibodies are produced, leading to damage of specific organs or tissues (Davidson & Diamond, 2001). Common examples include rheumatoid arthritis and lupus, where adaptive immune responses play a dominant role in the disease process.

Autoinflammatory DiseasesIn contrast, autoinflammatory diseases involve dysfunction of the innate immune system. These conditions result in episodes of unprovoked inflammation that occur without the involvement of autoantibodies or antigen-specific T cells (McGonagle & McDermott, 2006). Autoinflammatory diseases are often associated with genetic mutations that impact innate immune pathways, such as the inflammasome, a multi-protein complex that drives inflammation. Familial Mediterranean fever is an example of a well-characterized autoinflammatory disease.

Pathogenesis of Hidradenitis Suppurativa

Follicular OcclusionThe earliest event in the pathogenesis of HS is thought to be follicular occlusion due to abnormal keratinization. This process leads to the rupture of the hair follicle, which releases keratin and bacterial antigens into surrounding tissues, triggering an immune response (von Laffert et al., 2010). The immune system’s attempt to clear this debris results in chronic inflammation, abscess formation, and, eventually, sinus tracts and scarring.

Immune Dysregulation

Innate ImmunityStudies of HS lesions have revealed elevated levels of pro-inflammatory cytokines such as interleukin-1β (IL-1β), tumor necrosis factor-alpha (TNF-α), and interleukin-17 (IL-17), which point to the activation of the innate immune system (Kanni et al., 2015). These findings support the idea that HS is, at least in part, an autoinflammatory disorder, driven by innate immune responses that fail to resolve appropriately.

Adaptive ImmunityWhile evidence for the involvement of the adaptive immune system in HS is more limited, the presence of T-helper 17 (Th17) cells and elevated levels of IL-17 suggest that the adaptive immune system may also contribute to the disease process (Kelly et al., 2015). However, there is little evidence for the production of autoantibodies or autoreactive T cells that target specific self-antigens, meaning that HS does not fit neatly into the classical definition of an autoimmune disease (Schlapbach et al., 2019).

Genetic FactorsGenetic predisposition plays an important role in HS. Mutations in genes encoding components of the γ-secretase complex, such as NCSTN, PSENEN, and PSEN1, have been identified in familial cases of HS. These mutations disrupt Notch signaling pathways, which are critical for normal follicular keratinization and immune regulation (Wang et al., 2010). These findings further support the idea that HS involves dysregulation of both immune and keratinization processes.

Microbiome AlterationsAlterations in the skin microbiota may also contribute to the chronic inflammation seen in HS. Studies have found colonization of Staphylococcus aureus and other bacteria in HS lesions, although the exact role of these microorganisms in the disease process is still under investigation (Guet-Revillet et al., 2017). It is unclear whether these bacteria are primary drivers of inflammation or secondary colonizers that exacerbate an already dysfunctional immune response.

Classification of HS: Autoimmune or Autoinflammatory?

Arguments for Autoinflammatory Classification

• Innate Immune Activation: The predominance of elevated cytokines such as IL-1β and TNF-α, and the involvement of neutrophils and macrophages, supports the classification of HS as an autoinflammatory disease (Kanni et al., 2015).
• Genetic Mutations Affecting Innate Immunity: Mutations that affect innate immune pathways, such as those involved in the γ-secretase complex, point to autoinflammatory mechanisms (Pink et al., 2016).
• Lack of Autoantibodies: The absence of disease-specific autoantibodies further supports the idea that HS is not a classical autoimmune disease (Schlapbach et al., 2019).

Arguments for Autoimmune Features

• Adaptive Immune Involvement: Elevated IL-17 levels and the presence of Th17 cells indicate some role for the adaptive immune system in HS (Kelly et al., 2015).
• Response to Immunosuppressive Therapies: Some HS patients respond to therapies that target adaptive immune pathways, such as biologics inhibiting TNF-α and IL-12/23, suggesting that the adaptive immune system plays a role in some cases (Kimball et al., 2016).

Current ConsensusMost evidence suggests that HS is primarily an autoinflammatory disease with some autoimmune features. The dysregulation of both the innate and adaptive immune systems likely contributes to the complex pathogenesis of HS, but the innate immune system appears to play the more prominent role (Navarini et al., 2016).

Ayurvedic Perspective on Hidradenitis Suppurativa

In Ayurveda, HS is understood through the lens of Pitta and Kapha dosha imbalances. HS is seen as an inflammatory condition exacerbated by an accumulation of Ama (toxins), resulting from poor Agni (digestive fire). These toxins accumulate in the body and block the body’s channels (Srotas), leading to inflammatory skin conditions.

Pathophysiology According to Ayurveda

• Pitta Imbalance: HS is largely driven by an excess of Pitta (heat), which manifests as inflammation, pain, and infection in the skin.
• Kapha Imbalance: The involvement of Kapha (earth and water) leads to stagnation and obstruction in the body’s channels, resulting in the formation of abscesses, nodules, and sinus tracts.
• Ama Accumulation: Poor digestion leads to the buildup of Ama, which blocks the body’s channels and worsens inflammation.

Ayurvedic Approach to HS Management

The treatment of Hidradenitis Suppurativa (HS) in Ayurveda follows a holistic approach, focusing on long-term management by balancing the body’s Pitta and Kapha doshas, reducing inflammation, and promoting overall health and well-being. The Ayurvedic approach emphasizes the following key elements:

Addressing the Root Cause

The first step in managing HS in Ayurveda is identifying the underlying doshic imbalance that has led to the condition. For most patients, HS is seen as a disturbance in the Pitta and Kapha doshas, leading to inflammation and the accumulation of toxins (Ama). By understanding the individual’s Prakruti (innate constitution) and Vikruti (current imbalance), Ayurvedic practitioners create a personalized treatment plan that targets the root cause of the disease, rather than just the symptoms (Lad, 2002).

Stabilizing the Immune Response

Since HS is an autoimmune condition, stabilizing the immune system is critical. Ayurveda aims to modulate the immune response by balancing the Pitta and Kapha doshas, which helps reduce chronic inflammation and prevent the immune system from attacking healthy tissues. Herbal formulations rich in anti-inflammatory and immune-modulating properties, such as Neem and Turmeric, are used to calm the immune response and support long-term healing (Gupta & Ramesh, 2017).

Preventing Future Flare-Ups

A primary goal of Ayurvedic treatment is to maintain long-term remission by preventing future flare-ups. This is achieved by improving digestion and immunity through dietary modifications, such as avoiding spicy, oily, and heavy foods that aggravate Pitta and Kapha. In addition, lifestyle changes—such as following regular meal times, getting adequate rest, and managing stress through practices like yoga and meditation—play a vital role in keeping the body balanced and preventing HS from worsening (Sharma et al., 2020).

Detoxification

Ayurveda places a strong emphasis on detoxification to eliminate Ama (toxins) from the body that contribute to the progression of HS. A comprehensive detoxification therapy, is often recommended to cleanse the body’s channels. Specific Phase F clearance formulations and Phase F clearance formulations** are used to detoxify the digestive system, purify the blood, and restore balance to the doshas, promoting healing and preventing further complications (Dash & Sharma, 2005).

Conclusion

Hidradenitis Suppurativa is a multifactorial disease involving genetic predisposition, follicular occlusion, microbiome alterations, and immune dysregulation. Most evidence supports classifying HS as primarily an autoinflammatory disease, characterized by the activation of innate immune responses. However, the involvement of adaptive immune responses in some cases suggests that HS also has autoimmune features.

The Ayurvedic perspective provides a holistic understanding of HS, emphasizing the need to restore balance to the body’s Pitta and Kapha doshas, eliminate Ama, and improve overall digestion and immune health. A comprehensive management strategy that incorporates both modern medical insights and Ayurvedic principles may offer more effective long-term treatment for HS patients.nagement strategies for patients with HS.

References

1. Jemec GBE. Hidradenitis suppurativa. N Engl J Med 2012;366:158–64. [PubMed] [Google Scholar]

1. Ingram JR. Hidradenitis suppurativa: an update. Clin Med (Lond) 2016;16:70–3. [PMC free article] [PubMed] [Google Scholar]

1. Alikhan A, Lynch PJ, Eisen DB.. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol 2009;60:539–61. [PubMed] [Google Scholar]

1. Vinkel C, Thomsen SF.. Hidradenitis suppurativa: causes, features and current treatments. J Clin Aesthet Dermatol 2018;11:17–23. [PMC free article] [PubMed] [Google Scholar]

1. Vural S, Gundoğdu M, Akay BN. et al. Hidradenitis suppurativa: clinical characteristics and determinants of treatment efficacy. Dermatol Ther 2019;32:e13003. [PubMed] [Google Scholar]

1. Lyons AB, Shabeeb N, Nicholson CL. et al. Emerging medical treatments for hidradenitis suppurativa. J Am Acad Dermatol 2020;83:554–62. [PubMed] [Google Scholar]

1. Frew JW, Marzano AV, Wolk K. et al. A systematic review of promising therapeutic targets in hidradenitis suppurativa: a critical evaluation of mechanistic and clinical relevance. J Invest Dermatol 2021;141:316–24.e2. [PubMed] [Google Scholar]

1. Ben David C, Bragazzi NL, Watad A. et al. Hidradenitis suppurativa associated with systemic lupus erythematosus. Medicine (Baltimore) 2018;97:e0186. [PMC free article] [PubMed] [Google Scholar]

1. Blok JL, Li K, Brodmerkel C. et al. Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum. Br J Dermatol 2016;174:839–46. [PubMed] [Google Scholar]

1. Blanco R, Martínez-Taboada V, Villa I. et al. Long-term successful adalimumab therapy in severe hidradenitis suppurativa. Arch Dermatol 2009;145:580–4. [PubMed] [Google Scholar]

1. Scheinfeld N. Diseases associated with hidradenitis suppurativa: part 2 of a series on hidradenitis. Dermatol Online J 2013;19:18558. [PubMed] [Google Scholar]

1. Frew JW. Hidradenitis suppurativa is an autoinflammatory keratinization disease: a review of the clinical, histologic and molecular evidence. J Am Acad Dermatol Int 2020;1:62–72. [PMC free article] [PubMed] [Google Scholar]

1. Wang L, Wang FS, Gershwin ME.. Human autoimmune diseases: a comprehensive update. J Intern Med 2015;278:369–95. [PubMed] [Google Scholar]

1. Mulani S, McNish S, Jones D, Shanmugam VK.. Prevalence of antinuclear antibodies in hidradenitis suppurativa. Int J Rheum Dis 2018;21:1018–22. [PMC free article] [PubMed] [Google Scholar]

Related-

Know More About Ayurveda Hidradenitis suppurativa Treatment.

GET IN TOUCH

Schedule a Visit

Contact us